Skip to content

    Deepak Nitrite

    DEEPAKNTRGood
    Chemicals·14 Nov 2024
    Management Summary

    Deepak Nitrite delivered a resilient Q2 FY25, where strong volume growth and high utilization in the Phenolics business offset significant pricing and demand headwinds in the Advanced Intermediates (AI) segment, particularly from European agrochemical customers. The call was dominated by the strategic announcement of a ₹5,000 crore foray into Polycarbonates, marking a major downstream integration step. Management remains focused on a massive ₹14,000 crore capex cycle to diversify into advanced chemistries while maintaining a debt-free balance sheet.

    Highlights

    8

    • Consolidated Revenue reached ₹2,053 crores in Q2 FY25, a 14% YoY growth driven by the Phenolics segment.

    • EBITDA for Q2 stood at ₹319 crores, remaining flat YoY due to pricing pressure in Advanced Intermediates.

    • Phenolics segment revenue surged 29% YoY to ₹1,443 crores with a steady 15% EBIT margin.

    • Advanced Intermediates revenue declined to ₹606 crores (vs ₹670 crores YoY) with margins compressing to 8% due to agrochemical slowdown.

    • Announced a major ₹5,000 crore investment for Polycarbonate resins, including acquiring a 165,000 MTPA plant from Trinseo PLC in Germany.

    • Total capex plan of ₹14,000 crores outlined through 2027, with ₹7,000 crores already committed.

    • Maintained a zero-debt position on a net basis with a liquid surplus of approximately ₹800 crores.

    • Reported a healthy consolidated ROCE of 23% despite a challenging global macroeconomic environment.

    Concerns

    1

    • China Dumping and Overcapacity

    Key financials

    Single quarter

    06 metrics
    1. 01Revenue₹2,053 Cr+14.0%YoY
    2. 02EBITDA₹319 Cr0%YoY
    3. 03PAT₹194 Cr
    4. 04EBITDA Margin15%
    5. 05ROCE23%

    Segment breakdown

    • Phenolics₹1,443 Cr70.4%
    • Advanced Intermediates₹606 Cr29.6%
    Donut· Share of Revenue

    Guidance & targets

    4
    CategoryTargetPriority
    Capex
    Total Capex Plan
    ₹14,000 crores
    		High
    Capacity
    Polycarbonate Resin Capacity
    165,000 metric tonnes
    		High
    Capacity
    Nitric Acid Project Commissioning
    Commissioning
    		High
    Profitability
    EBITDA addition from new projects
    2% to 4%
    		Medium

    Risks & concerns

    4
    RiskSeverity

    China Dumping and Overcapacity

    Persistently underpriced product availability from China has prevented a broader recovery in pricing for Advanced Intermediates. — Both acknowledged

    high

    Agrochemical Sector Cyclicality

    Weak demand trends and destocking in Europe have led to reduced offtake and muted realizations. — Management acknowledged

    medium

    Logistical Challenges

    Increasing freight rates and longer sailing times have exacerbated short-term challenges. — Management acknowledged

    low

    Areas of Evasion(1)

    • Specific IRR and payback periods for the Polycarbonate project were deferred until the full 'basket' of related projects (BPA, Phenol expansion) is announced.

    Q&A highlights

    3

    “Trinseo is not exiting the business. They're just exiting the manufacturing of polycarbonate resins... they will look at buying the resin from Deepak as we relocate their assets to India.”

    Clarifies that the technology partner remains a customer, de-risking the massive investment and ensuring immediate offtake.

    asked by Rohit Nagraj, Centrum Broking

    2 min read5 chapters

    Detailed Narrative

    01

    Strategic Leap into Advanced Materials

    Deepak Nitrite has officially commenced its foray into Advanced Materials through its subsidiary, Deepak Chem Tech Limited (DCTL). The board approved a ₹5,000 crore project to manufacture polycarbonate resins, leveraging a technology licensing and asset purchase agreement with Trinseo PLC. This includes acquiring a 165,000 MTPA plant currently located in Germany, which will be relocated to India. This move addresses India's 240,000 MTPA demand, which is currently 100% met through imports, positioning Deepak as a pioneer in domestic production.

    02

    Phenolics Segment Anchors Performance

    The Phenolics business continues to be the primary growth engine, with Q2 revenues growing 29% YoY to ₹1,443 crores. Despite a 'brutal summer' affecting operations, the segment maintained a healthy 15% EBIT margin. High capacity utilization and favorable domestic consumption trends in the phenol and acetone chain helped offset the weakness in other business areas. Management noted that the segment's resilience is a result of deep integration and high wallet share with domestic customers, who contribute 84% of total revenue.

    03

    Advanced Intermediates Face Cyclical Headwinds

    The Advanced Intermediates (AI) segment saw a revenue dip to ₹606 crores from ₹670 crores YoY, with EBIT margins contracting to 8%. This was primarily due to a slowdown in the global agrochemical sector and destocking by European customers, leading to a roughly ₹100 crore sequential revenue impact. While volumes were maintained by pivoting to non-traditional geographies, realizations remained muted due to competitive pricing from China. Management expects a recovery in this segment starting from Q4 FY25 as destocking cycles conclude.

    04

    Massive Capex and Project Pipeline

    The company is in the midst of a transformative ₹14,000 crore capex cycle. Key projects nearing completion include the Nitric Acid plant and photochlorination/hydrogenation blocks, all expected in H2 FY25. Looking further ahead, MIBK, MIBC, and Acetophenone projects are slated for H1 FY26. Management estimates these new investments will add 2% to 4% to the consolidated EBITDA margin once fully operational. The company's zero-debt status and ₹800 crore cash surplus provide a strong foundation for funding these ambitious expansions.

    05

    Operational Efficiency and R&D Focus

    Deepak Nitrite reported a consolidated ROCE of 23%, reflecting high capital efficiency even during a heavy investment phase. The new R&D center near Vadodara is on track for commissioning in H2 FY25, with ₹115 crore capex allocated. This facility is expected to significantly enhance capabilities in advanced chemistries and support the polycarbonate compounding strategy. Management emphasized that their integrated model—spanning from basic chemicals to advanced intermediates and now resins—creates a 'resilient bulwark' against global volatility🌐.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.